These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14639924)

  • 1. [A life-long pursuit of liver failure as clinician].
    Fujiwara K
    Nihon Shokakibyo Gakkai Zasshi; 2003 Nov; 100(11):1273-84. PubMed ID: 14639924
    [No Abstract]   [Full Text] [Related]  

  • 2. Stem cell therapies for liver failure and cirrhosis.
    Zhang Z; Wang FS
    J Hepatol; 2013 Jul; 59(1):183-5. PubMed ID: 23353868
    [No Abstract]   [Full Text] [Related]  

  • 3. [Severity of liver inflammation is associated with enhanced hepatic Th1 cytokine in patients with HBV-related liver cirrhosis].
    Zhang P; Chen T; Gong Y; Shen LW; Gao T; Xue F; Xia Q; Li H
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):861-3. PubMed ID: 21138639
    [No Abstract]   [Full Text] [Related]  

  • 4. Cryopreserved fetal liver cell transplants support the chronic failing liver in rats with CCl4-induced cirrhosis.
    Ochenashko OV; Volkova NA; Mazur SP; Somov AY; Fuller BJ; Petrenko AY
    Cell Transplant; 2006; 15(1):23-33. PubMed ID: 16700327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation.
    Bernard PH; Le Bail B; Cransac M; Barcina MG; Carles J; Balabaud C; Bioulac-Sage P
    J Hepatol; 1995 Apr; 22(4):495-9. PubMed ID: 7665869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of pro-apoptotic effect of liver failure plasma on primary human hepatocytes and its modulation by molecular adsorbent recirculation system therapy.
    Saich R; Selden C; Rees M; Hodgson H
    Artif Organs; 2007 Sep; 31(9):732-42. PubMed ID: 17725701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of methods to remove protein-bound substances in liver failure.
    Hughes RD
    Int J Artif Organs; 2002 Oct; 25(10):911-7. PubMed ID: 12456030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic liver diseases: what physicians and patients hope for. New strategies against liver cell death].
    Vetter C
    MMW Fortschr Med; 2003 Jun; 145(26):10. PubMed ID: 12916330
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasma exchange combined with liver transplantation treatment in a child with liver failure].
    Mo GS; Zhang JL; Wu ZL
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):473-4. PubMed ID: 21924066
    [No Abstract]   [Full Text] [Related]  

  • 10. Nutrition in end stage liver disease.
    Kondrup J
    Best Pract Res Clin Gastroenterol; 2006; 20(3):547-60. PubMed ID: 16782528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange as a rescue strategy for hepatic failure.
    Agishi T; Nakagawa Y; Teraoka S; Kubo K; Nakazato S; Ota K
    ASAIO J; 1994; 40(1):77-9. PubMed ID: 8186498
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative effectiveness of different treatment methods of liver failure].
    Kutepov DE; Vershinina MG; Pasechnik IN; Sal'nikov PS
    Khirurgiia (Mosk); 2014; (3):32-6. PubMed ID: 24781068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B removal by plasma exchange.
    Lew SQ
    J Clin Pharm Ther; 2009 Feb; 34(1):115-7. PubMed ID: 19125909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic renal disease in cirrhosis: adding insult to injury.
    Macnaughtan J; Tritto G; Jalan R
    Liver Int; 2010 May; 30(5):639-41. PubMed ID: 20214735
    [No Abstract]   [Full Text] [Related]  

  • 15. Intramuscular transplantation of engineered hepatic tissue constructs corrects acute and chronic liver failure in mice.
    Navarro-Alvarez N; Soto-Gutierrez A; Chen Y; Caballero-Corbalan J; Hassan W; Kobayashi S; Kondo Y; Iwamuro M; Yamamoto K; Kondo E; Tanaka N; Fox IJ; Kobayashi N
    J Hepatol; 2010 Feb; 52(2):211-9. PubMed ID: 20022655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal Liver Support Systems in Paediatric Liver Failure.
    Jain V; Dhawan A
    J Pediatr Gastroenterol Nutr; 2017 Jun; 64(6):855-863. PubMed ID: 28248208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible nizatidine-induced subfulminant hepatic failure.
    Chey WD; Kochman ML; Traber PG; Appelman HD; Gumucio JJ
    J Clin Gastroenterol; 1995 Mar; 20(2):164-7. PubMed ID: 7769203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of autologous CD34-depleted bone marrow mononuclear cell transplantation via the hepatic artery in five patients with liver failure.
    Park CH; Bae SH; Kim HY; Kim JK; Jung ES; Chun HJ; Song MJ; Lee SE; Cho SG; Lee JW; Choi JY; Yoon SK; Han NI; Lee YS
    Cytotherapy; 2013 Dec; 15(12):1571-9. PubMed ID: 23849977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tipping the balance.
    Drew L
    Nature; 2018 Dec; 564(7736):S74-S75. PubMed ID: 30568206
    [No Abstract]   [Full Text] [Related]  

  • 20. Is plasma exchange effective in prevention of hepatic transplantation in fulminant Wilson disease with hepatic failure?
    Akyildiz BN; Yildirim S; Kondolot M; Arslan D
    J Pediatr Gastroenterol Nutr; 2011 Jun; 52(6):778-80. PubMed ID: 21593651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.